Data / Research funding / California / Raft Pharmaceuticals, LLC
Raft Pharmaceuticals, LLC: 4 NIH awards ($6.3M), fiscal years 2021 to 2026
Raft Pharmaceuticals, LLC in San Diego, CA is funded under 4 NIH awards ($6.3M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- KD1LJTFV7DN8
- State
- California
Awards
4 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Targeting lipid rafts for treatment of asthma | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,043,597 | June 20, 2019 | March 31, 2027 | KOGAN, YAKOV | reporter.nih.gov |
| Novel biologic to treat chemotherapy-induced neuropathic pain | NIH | National Cancer Institute | 2022 to 2023 | $2,049,964 | September 19, 2022 | August 31, 2025 | KOGAN, YAKOV | reporter.nih.gov |
| Targeting TLR4-lipid rafts to prevent postoperative pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $698,036 | September 21, 2023 | August 31, 2025 | DOUGHERTY, PATRICK M | reporter.nih.gov |
| AAV-AIBP Therapy for Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2023 | $500,000 | September 30, 2022 | May 31, 2025 | JU, WONKYU | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2025 | 1 | $1,046,403 | 0 | $0 |
| 2024 | 2 | $1,280,404 | 0 | $0 |
| 2023 | 4 | $2,717,767 | 0 | $0 |
| 2022 | 2 | $1,247,023 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | PAR-25-095 | NIH | 93.866 | November 6, 2026 | $350,000 | Same assistance listing 93.866 as 1 award here |
| Functional Target Validation for Alzheimer's Disease-Related Dementias | RFA-NS-26-034 | NIH | 93.853 | November 6, 2026 | Not listed | Same assistance listing 93.853 as 1 award here |
| Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required) | PAR-27-007 | NIH | 93.853 | November 10, 2026 | Not listed | Same assistance listing 93.853 as 1 award here |
| Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed) | RFA-AG-27-010 | NIH | 93.866 | November 10, 2026 | Not listed | Same assistance listing 93.866 as 1 award here |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) | RFA-NS-26-001 | NIH | 93.853 | November 10, 2026 | Not listed | Same assistance listing 93.853 as 1 award here |
| Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) | RFA-NS-26-030 | NIH | 93.853 | November 10, 2026 | Not listed | Same assistance listing 93.853 as 1 award here |
| NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) | PAR-24-089 | NIH | 93.279 | November 13, 2026 | $750,000 | Same assistance listing 93.279 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.279 | November 16, 2026 | $50,000 | Same assistance listing 93.279 as 1 award here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | PAR-25-096 | NIH | 93.866 | November 17, 2026 | $200,000 | Same assistance listing 93.866 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.279 | November 18, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.279 | November 18, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) | PAR-25-052 | NIH | 93.853 | November 19, 2026 | Not listed | Same assistance listing 93.853 as 1 award here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.866 | November 23, 2026 | $375,000 | Same assistance listing 93.866 as 1 award here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.279 | November 24, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | RFA-OD-27-008 | NIH | 93.853 | December 2, 2026 | Not listed | Same assistance listing 93.853 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.279 | December 3, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.279 | December 3, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.279 | December 4, 2026 | Not listed | Same assistance listing 93.279 as 1 award here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.